ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,336.31
-0.87%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ClearPoint Neuro Inc (CLPT)

  7. ClearPoint Neuro Inc (CLPT) Noticias

CLPT ClearPoint Neuro Inc

5.94
0.42 (7.61%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ClearPoint Neuro Inc CLPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.42 7.61% 5.94 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.59 5.59 5.88 5.87 5.52
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:05GLOBEClearPoint Neuro to Present Novel Research and Exhibit at..
29/4/202407:00GLOBEClearPoint Neuro Announces FDA Clearance of Prism Bone..
24/4/202415:05GLOBEClearPoint Neuro Announces Initiation of Limited Market..
23/4/202415:05GLOBEClearPoint Neuro to Announce First Quarter 2024 Results May..
16/4/202415:05GLOBEClearPoint Neuro Congratulates its Partner AviadoBio on..
19/3/202407:07GLOBEClearPoint Neuro Congratulates its Partner PTC Therapeutics..
12/3/202415:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full-Year 2023..
11/3/202407:00GLOBEJournal of Neurosurgery Publication Demonstrates Distinct..
08/3/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:05GLOBEClearPoint Neuro to Announce Fourth Quarter and Full Year..
01/3/202407:00EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
29/2/202407:00GLOBEClearPoint Neuro Announces Pricing of Public Offering of..
28/2/202415:45GLOBEClearPoint Neuro Launches Proposed Public Offering of Common..
23/2/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:05GLOBEClearPoint Neuro Announces FDA Clearance and First-in-Human..
06/2/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202415:05GLOBEClearPoint Neuro Announces Installation and First Procedure..
22/1/202415:05GLOBEClearPoint Neuro Announces First EU MDR Certification..
16/1/202407:00GLOBEClearPoint Neuro Announces FDA Clearance for SmartFrame OR™..
08/1/202415:07EDGAR2Form 8-K - Current report
08/1/202415:05GLOBEClearPoint Neuro Reports Fourth Quarter and Full Year 2023..
03/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202410:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202410:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202308:22EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202316:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:05GLOBEClearPoint Neuro Reports Third Quarter 2023 Results
26/10/202315:05GLOBEClearPoint Neuro to Announce Third Quarter 2023 Results..
12/10/202313:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202311:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:06EDGAR2Form 8-K - Current report
08/8/202315:05GLOBEClearPoint Neuro Reports Second Quarter 2023 Results
01/8/202315:48EDGAR2Form 8-K - Current report
25/7/202315:05GLOBEClearPoint Neuro to Announce Second Quarter 2023 Results..
11/7/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
CLPT
ClearPoint Neuro
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados